Emergent BioSolutions (EBS) Total Debt Growth (1y) (2011 - 2026)
Emergent BioSolutions (EBS) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 37.52% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -9.19% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 0.63% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Emergent BioSolutions | 432.85 Mn | 271.35 Mn | 84.10 Mn | -13.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.84% |
| Dec 31, 2025 | -13.80% |
| Sep 30, 2025 | 0.20% |
| Jun 30, 2025 | 49.40% |
| Mar 31, 2025 | 49.03% |
| Dec 31, 2024 | 48.65% |
| Sep 30, 2024 | 47.66% |
| Jun 30, 2024 | -0.22% |
| Mar 31, 2024 | -0.22% |
| Dec 31, 2023 | -0.45% |
| Sep 30, 2023 | -56.57% |
| Jun 30, 2023 | -43.55% |
| Mar 31, 2023 | -44.14% |
| Dec 31, 2022 | -44.59% |
| Sep 30, 2022 | 26.28% |
| Jun 30, 2022 | -3.83% |
| Mar 31, 2022 | -3.79% |
| Dec 31, 2021 | -3.76% |
| Sep 30, 2021 | -3.68% |
| Jun 30, 2021 | 5.74% |